Nine clinical isolates of Enterobacteriaceae (six Escherichia coli and three Proteus mirabilis) isolated in three Parisian hospitals between 1989 and 2000 showed a particular extended-spectrum cephalosporin-resistance profile characterized by resistance to cefotaxime and aztreonam but not to ceftazidime. CTX-M-1, CTX-M-2, CTX-M-9, CTX-M-14 and two novel plasmid-mediated CTX-M L-lactamases (CTX-M-20, and CTX-M-21) were identified by polymerase chain reaction and isoelectric focusing (pI s 8) and were associated in eight cases with TEM-1 (pI = 5.4) or TEM-2 (pI = 5.6) L-lactamases. We used internal ISEcp1 and IS26 forward primers and the CTX-M consensus reverse primer to characterize the CTX-M L-lactamase promoter regions and showed their high degree of structure diversity. We found upstream of some bla CTXÀM genes, a 266-bp sequence 100% identical to the sequence upstream of the Kluyvera ascorbata Llactamase gene, suggesting that this chromosomal enzyme is the progenitor of the CTX-M-2/5 cluster. ß
Introduction
Extended-spectrum L-lactamases (ESBLs) were ¢rst isolated from Klebsiella pneumoniae in Germany (SHV-2 in 1983) shortly after the introduction of the new oxyiminocephalosporins as cefotaxime, aztreonam and ceftazidime [1] . They were subsequently isolated in France (TEM-3 in 1984) and then from many Enterobacteriaceae species worldwide. These enzymes hydrolyze oximino-L-lactams, such as the third-generation cephalosporins. According to the structural classi¢cation of Ambler [2] and the latest function scheme of Bush et al. [3] , these ESBLs are generally class A enzymes of the 2be group and are thus highly susceptible to L-lactamase inhibitors (e.g. clavulanate, tazobactam). They are usually derivatives of the common plasmid-mediated TEM-1, -2 and SHV-1 L-lactamases, resulting from the substitution of one or several amino acids [1] .
New enzyme groups with a typical ESBL-resistance phenotype but non-TEM^non-SHV derivatives have recently been described. These include PER-1 [4, 5] , PER-2 [6] , VEB-1 [7] , GES-1 [8] , BES-1 [9] and the CTX-M group [10] . The latter is a small, but growing, family of plasmidencoded ESBLs that preferentially hydrolyze cefotaxime. These enzymes are not closely related to TEM or SHV L-lactamases (less than 40% identity) but are typical members of Ambler's class A. So far, 20 CTX-M enzymes have been described between 1989 and 2001 in various enterobacterial species but mostly clinical isolates of Salmonella typhimurium, Escherichia coli and K. pneumoniae. The ¢rst two of these enzymes were isolated in Europe in 1989 : MEN-1 (also known as CTX-M-1) from an Italian patient in France and CTX-M-1 in Germany [11, 12] . The others have been reported in a very wide geographic area including Europe, South America and the Middle and Far East.
CTX-M ESBLs can be divided into four clusters based on their protein sequences [24] : (1) CTX-M-2-type with CTX-M-2 [13] , -M-4 [14] , -M-5 [15] , -M-6 [16] , -M-7 [16] and Toho-1 [17] ; (2) CTX-M-1-type with CTX-M-1 [13] , -M-3 [18] , -M-10 [19] , -M-12 [20] , -M-15 [21] ; (3) with CTX-M-9 [22] , -M-14 [23] -M-16 [24] , -M-18, -M-19 [25] and Toho-2 [26] ; and (4) with CTX-M-8 [27] . One of these clusters (CTX-M-2-type) was recently shown (Humeniuk, C., personal data) to exhibit 98% identity with the chromosomally-encoded L-lactamase of Kluyvera ascorbata.
Many plasmid-encoded drug-resistance markers form part of transposons that are often £anked by IS elements [28] . The involvement of insertion sequences mobilizing Llactamase-encoding genes such as IS26 (SHV-2a [29] and ACC-1 [30] ) or as ISEcp1 (CMY-4 ; Stapleton, P.D., Abs1457, 39th ICAAC 1999, San Francisco, EMBL accession number AJ242809) and plasmid-mediated class A CTX-M-encoding genes (CTX-M-5; Humeniuk, C., personal data, EMBL accession number AF286192) or CTX-M-15 [21] led us to use polymerase chain reaction (PCR) with speci¢c IS26 and ISEcp1 primers to investigate the mechanism by which CTX-M genes are acquired in enterobacterial species.
This paper reports the nucleotide sequences of these CTX-M enzymes and their promoter regions, isolated in three Parisian hospitals.
Materials and methods

Bacterial strains and plasmids
The nine clinical strains used in this work are listed in Table 1 and were identi¢ed with API-20 E systems (Biome ¤rieux SA, Marcy l'Etoile, France). The E. coli SCI strain was isolated from an Italian patient. E. coli J53-2 rifR and E. coli XL-1 (Stratagene, La Jolla, CA, USA) were used for resistance transfer assays (conjugation and electroporation).
Plasmid DNA was extracted from the clinical strains, transconjugants and transformants by the Kado and Liu method [31] . Plasmid DNA was detected by electrophoresis in a 0.8% agarose gel. The molecular sizes of plasmid DNAs were estimated by comparison with plasmids of known sizes, pIP173 (126 kb), pCCF04 (85 kb) and pIP135 (70 kb).
L-Lactam susceptibility
Antibiotic disks (Bio-Rad SA, Marnes-la-Coquette, France) were used routinely to construct antibiograms by a di¡usion method on Mueller^Hinton agar (MH) (Bio-Rad SA). Minimal inhibitory concentrations (MICs) were determined by a dilution method on MH agar with an inoculum of 10 4 CFU per spot, delivered with a multipoint inoculator. ESBLs were detected by the standard disk synergy test [32] .
Cefotaxime-resistance transfer assays
We attempted to transfer cefotaxime-resistance genes directly by use of a mating-out assay with each donor strain into a rifampin-resistant recipient strain E. coli J53-2. An equal volume (200 Wl) of each culture was plated onto solid Drigalski agar plates (Bio-Rad) and the plates were incubated at 37 ‡C for 18 h. Transconjugants were then selected on Drigalski agar plates containing rifampin (250 Wg ml 31 ) and cefotaxime (2.5 Wg ml 31 ). E. coli strains liable to produce colicins were plated on MH agar plates that had been plated with E. coli J53-2.
Plasmid DNA was isolated by an alkaline lysis procedure (High Pure Plasmid Isolation kit1, Roche Molecular Biochemicals, Meylan, France) and 5 Wl was transformed into 40 Wl of E. coli XL-1 cells by electroporation according to the manufacturer's instructions (Bio-Rad). Transformants were incubated for 2 h at 37 ‡C and mated on Drigalski medium supplemented with cefotaxime (2.5 Wg ml 31 ).
Isoelectric focusing (IEF) of L-lactamases
All clinical isolates, transconjugants and transformants were grown in 100 ml of Trypticase soy broth (Bio-Rad). The bacteria collected by centrifugation were suspended with 1 ml of phosphate bu¡er (10 mM, pH 7.0) and sonicated at 4 ‡C with a Vibracell1 apparatus (three times for 20 s, P = 60 W) before being subjected to IEF on a pH 3.5^10 ampholine polyacrylamide gel at 5% for 18 h at 6 W, 400 V and 15 mA with a Multiphor apparatus (Pharmacia LKB) [33] . L-Lactamase activity was detected with the chromogenic nitroce¢n (Oxoid, Dardilly, France). Isoelectric points (pI) were estimated with pI markers, TEM-1 (pIP1100, pI = 5.4), TEM-2 (RP4, pI = 5.6), TEM-3 (pCFF04, pI = 6.3), SHV-4 (pUD21, pI = 8.2) and CMY2b (pSenf, pI s 9).
Characterization of L-lactamase-encoding genes (bla)
OT3 and OT4 primers were used to amplify the putative bla TEM genes and OS5 and OS6 were used to amplify the putative bla SHV genes in the nine clinical isolates [34, 35] . The bla TEM genes were characterized by PCR^RFLP (restriction fragment length polymorphism) [34] or by sequencing using OT3 and OT4 as sequencing primers. For speci¢c detection of the bla CTXÀM genes, consensus primers (MA1 and MA2) were chosen from regions with high levels of sequence homology to the bla CTXÀM genes known in January 2000 (Table 2 ). After sequencing the PCR products obtained, we used the BLAST program [36] to look for sequence homology with the other bla CTXÀM genes. More speci¢c primers for each cluster of the CTX-M family were then designed to amplify the entire coding sequences of the bla CTXÀM genes ( Table 2) . Both strands of the PCR products were sequenced by the 
Abbreviations: S: G or C, Y: C or T, R: A or G, Tnp: transposase. Sanger method [37] with an Applied Biosystems sequencer (model ABI 377).
The nucleotide sequences and the deduced protein sequences were analyzed with the BLAST and Clustal W programs (multiple sequence alignment, pairwise comparisons of sequences and dendrograms) [36, 38] .
The EMBL accession numbers were AJ416340 for the strain SCI, AJ416341 for the strains TN01 and TN02, AJ416342 for the strains Proteus mirabilis 2991 and E. coli 5402, AJ416343 for the strain DID, AJ416344 for the strain TLR, AJ416345 for the strain RAJ, and AJ416346 for the strain TRA.
Exploration of the promoter regions of bla CTX ÀM genes
The recent analysis of the promoter regions in bacteria producing plasmidic L-lactamases revealed mobile insertion sequences, such as IS26 and ISEcp1, upstream from the resistance gene [21, 29, 30] . These sequences ensure the transfer of the resistance genes from the bacterial chromo- some to the plasmids. To test this hypothesis in our nine clinical strains, we used the internal IS26 and ISEcp1 forward primers and the CTX-M reverse consensus primer (MA3) to investigate the promoter regions of the bla CTXÀM genes. The ¢rst ISEcp1 primer, ISEcp1U1, includes the right inverted repeat sequence and the second ISEcp1 primer, ISEcp1U2, includes a part of the transposase gene ( Table 2 ). The IS26 primer was also chosen because it include a part of the transposase gene (Table 2) . PCR and DNA sequencing were carried out as previously described.
Results and discussion
L-lactam susceptibility
The L-lactams MICs of the nine Enterobacteriaceae clinical isolates, their E. coli J53-2 transconjugants and their E. coli XL-1 transformants are listed in Table 3 .
The results of the agar disc di¡usion assay with cefotaxime and aztreonam resistance and the marked synergistic e¡ect between clavulanic acid and these two antibiotics suggested the presence of a novel ESBL. In contrast, the susceptibility to ceftazidime was not a¡ected.
These ESBL-producing strains exhibited a high level of resistance to penicillins, cephalothin, cefuroxime (MICs s 128 Wg ml 31 ), and cefotaxime (MICs = 16^128 Wg ml 31 ). They were susceptible or intermediate to aztreonam (MICs = 1^16 Wg ml 31 ) but remained susceptible to ceftazidime (MICs = 0.12^2 Wg ml 31 ) and imipenem (MICs = 0.25^1 Wg ml 31 ). Clavulanate partially restored the activities of penicillins and totally restored the activity of the other L-lactams. All of the strains were susceptible to a combination of clavulanate and broad-spectrum cephalosporins (MICs = 0.030 .1 Wg ml 31 ). The 'cefotaximase'-resistance phenotype, was similar to that observed in Enterobacteriaceae producing CTX-M-type L-lactamases [10] (excepted for CTX-M19) [25] . This strongly suggested that the nine clinical isolates contained a CTX-M-type L-lactamase.
Transfer of L-lactam resistance and plasmid DNA
Cefotaxime = resistant E. coli J53-2 were only obtained from E. coli TN01, TN02, TRA and 5402 and showed the same resistance phenotype as the clinical isolates (Table 3) . The probable production of colicins by the two other E. coli strains (RAJ and SCI), as suggested by an inhibition zone-growth observed, explained that mating-out assays Fig. 2 . Schematic representation of the promoter regions of the bla CTXÀM genes from the nine clinical Enterobacteriaceae isolates. Row 1, E. coli 5402 and P. mirabilis 2991; 2, E. coli SCI; 3, E. coli TRA, E. coli TN01 and E. coli TN02; 4, E. coli RAJ ; 5, P. mirabilis TLR and P. mirabilis DID. The position of the ISEcp1 U1 primer is indicated by an arrow head. X, Y, KLU, see Section 3. failed to give transconjugants for these two strains (data not shown). The electroporation of their plasmid DNA into E. coli XL-1 successfully transferred cefotaxime resistance. Only one large plasmid (between 100 and 130 kb) was detected in the clinical isolates of E. coli and their transconjugants or their transformants. No transfer could be obtained from the three P. mirabilis clinical isolates, either by mating-out experiments or by electroporation, although one large plasmid (70^85 kb) was detected in the three strains.
Characterization of L-lactamases
IEF revealed two major nitroce¢n-hydrolysing bands in eight clinical isolates, in their transconjugants or transformants. The ¢rst one was characterized by an acid pI (5.4 for E. coli and 5.6 for P. mirabilis), the second one by an alkaline pI (8.3 for P. mirabilis DID and TLR, 8.4 for E. coli TN01, TN02, TRA and RAJ or 8.7 for E. coli SCI and 5402) (results not shown). P. mirabilis 2991 exhibited only the band with an alkaline pI (8.7).
Sequencing and PCR^RFLP showed that the pI = 5.4 Llactamases corresponded to the bla TEMÀ1 gene in the six E. coli strains and that the pI = 5.6 enzyme corresponded to the bla TEMÀ2 in the two P. mirabilis strains (results not shown). No ampli¢cation products were obtained with SHV primers.
Due to the ESBL-resistance phenotype obtained and the presence of a L-lactamase with an alkaline pI ( s 8), consensus primers (MA1 and MA2) allowed to amplify and sequence a 450-bp internal fragment of the CTX-M L-lactamases genes from the nine clinical isolates. The entire coding sequences of the nine CTX-M genes were subsequently ampli¢ed with speci¢c primers and sequenced. The analysis of the nucleotide sequences and the deduced protein sequences ( Fig. 1 ) with BLAST and Clustal W showed that E. coli SCI, E. coli 5402 and P. mirabilis 2991 produced a CTX-M-1-type enzyme [13] .
The P. mirabilis DID contained a CTX-M-2-type enzyme [13] and P. mirabilis TLR produced a novel CTX-M enzyme , showing 99% identity with CTX-M-2 [13] .
Finally, the enzymes produced by the four others E. coli strains exhibited 98^100% identity with CTX-M-9 [22] described in Spain. The enzyme produce by E. coli RAJ was similar to CTX-M-9. The CTX-M enzymes produced by E. coli TN01 and TN02 strains were similar to CTX-M-14 [23] recently described in Korea. Comparison with data- Fig. 3 . Multiple alignment of the nucleotide sequences of the promoter regions of the bla CTXÀM genes from the nine clinical Enterobacteriaceae isolates and the promoter regions of bla CTXÀMÀ5 , (EMBL accession number AJ272538), bla CTXÀMÀ15 , bla CTXÀM -type from E. coli ACH-13, (EMBL accession number AF252622), bla TohoÀ1 (GenBank accession number D37830) and bla TohoÀ2 (GenBank accession number D89862). Row 1, E. coli SCI, E. coli 5402 and P. mirabilis 2991; 2, bla CTXÀMÀ15 ; 3, E. coli TRA, E. coli TN01 and E. coli TN02; 4, bla TohoÀ2 ; 5, bla CTXÀMÀ5 ; 6, bla CTXÀM -type of E. coli ACH-13; 7, E. coli RAJ; 8, P. mirabilis TLR and P. mirabilis DID ; 9, bla TohoÀ1 . IRR, right inverted repeat of ISEcp1 is shaded. The^35 and^10 putative promoter regions are underlined. The sequence of the recombination site of ORF341 is in italics.
bases showed that the E. coli TRA strain also presented a novel CTX-M enzyme (CTX-M-21).
Exploration of the promoter regions of bla CTX ÀM genes
All of the strains were ampli¢ed with the ISEcp1U1 primer. Sequencing of the PCR products revealed a ISEcp1 fragment containing typical 335 and 310 putative promoters region (as suggested by Karim et al. [21] ) and a right inverted repeat upstream from the CTX-M genes in all of the strains except three (RAJ, TLR and DID) (Figs.  2 and 3 ). In these three strains, we found a 17-bp sequence identical to the end of the adjacent region of open reading frame (ORF) 341 immediately after the beginning of the sequence (including only the putative 335 promoter region). This 17-bp sequence correspond to the recombination site probably involved in the insertion of some plasmid-mediated class C L-lactamases such as DHA-1 and CMY-1 into SulI-type complex integrons [39] . The insertion of this 17-bp sequence could form a typical 310 promoter region (16 bp downstream) (Fig. 3) , thus forming a complete putative promoter. PCR using upper primer internal of ORF341 5P-TGCATGGAAAAGCGTGGGAT-3P [40] and reverse lower primer MA3 (Table 2) were negative for these three strains.
The two CTX-M-2-like L-lactamase-producing strains (TLR and DID), contained a sequence of 266 bp (KLU) (Fig. 2) between the 17 bp sequence and the bla gene. This sequence was 100% identical to the region found directly upstream from the bla gene encoding the chromosomal Llactamase of K. ascorbata (C. Humeniuk, personal data, EMBL accession number AJ272538) (Fig. 3) . This con¢rms that the chromosomal L-lactamase of K. ascorbata is the progenitor of the CTX-M-2^CTX-M-5 cluster within the CTX-M L-lactamases group.
In the strain RAJ, we found a 94-bp sequence between the 17 bp originated from the adjacent region of ORF341 and the start codon of the L-lactamase gene; the last 42 bp of this sequence (Y sequence) (Fig. 2) were also found upstream from the start codon of the L-lactamase genes of the strains TRA, TN01 and TN02. Like the RAJ strain, these strains all produce an enzyme belonging to the CTX-M-9^Toho-2 cluster. This region could be a part of the chromosome of a Gram-negative rod, that is thought to be the progenitor of this cluster, as observed for K. ascorbata and the CTX-M-2-like L-lactamases.
PCR using the IS26 primer produce amplicons in E. coli 5402 and P. mirabilis 2991, which produce a CTX-M-1 Llactamase. Sequencing (Figs. 2 and 3 ) revealed a 216-bp sequence downstream of the inverted repeat of IS26. This sequence was 100% identical with the end of ISEcp1. This organization (IS26 and end of ISEcp1) was also found, in its entirety, upstream of the bla gene encoding the ACC-1 L-lactamase [30] . Moreover, in strains E. coli 5402, P. mirabilis 2991 and E. coli SCI, all of which produce a CTX-M-1 L-lactamase, a 79-bp region with an identical sequence (X sequence) (Fig. 2) was found between the right inverted repeat of ISEcp1 and the start codon of the L-lactamase gene. As previously, the probable progenitor hypothesis can be made.
These results showed the diversity and the complexity of the promoter regions of bla CTXÀM genes carried by enterobacterial strains isolated in Paris.
